Apellis Pharmaceuticals
+$0.33 (+0.74%) Today
$0.00 (0.00%) As of 8:28 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.
About APLS
Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic and complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.
CEO
Cedric Francois
Employees
476
Headquarters
Waltham, Massachusetts
Founded
2009
APLS Key Statistics
Market cap
4.77B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.40M
High today
$45.81
Low today
$42.63
Open price
$45.08
Volume
1.24M
52 Week high
$73.00
52 Week low
$27.50
Analyst ratings
81%
of 16 ratings
Buy
81.3%
Hold
12.5%
Sell
6.3%
APLS Earnings
-$2.72
-$1.50
-$0.29
$0.93
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 3, After Hours